Increasing evidence suggests that JAK proteins are a potential target for immunosuppressive drugs against psoriasis and other immune-mediated skin diseases, especially those elicited by epidermal keratinocytes exposed to massive amounts of proinflammatory cytokines, including IFN-γ and IL-22 [15, 16, 30]. Here, IL22 is linked to psoriasis.